The future of best practice

This publication has 30 references indexed in Scilit:

• Comparative Dose Efficacy Study of Atorvastatin Versus Simvastatin, Pravastatin, Lovastatin, and Fluvastatin in Patients With Hypercholesterolemia (The CURVES Study) fn1fn1This study was supported by Parke-Davis, Division of Warner Lambert Company, Morris Plains, New Jersey. Manuscript received August 20, 1997; revised manuscript received and accepted November 24, 1997.
  The American Journal of Cardiology, 1998
• Rationale and Design of the Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering (MIRACL) Study That Evaluates Atorvastatin in Unstable Angina Pectoris and in Non–Q-Wave Acute Myocardial Infarction
  The American Journal of Cardiology, 1998
• Relationship Between Serum Cholesterol and the Risk of Acute Myocardial Infarction in a Screened Cohort in Okinawa, Japan
  Japanese Circulation Journal, 1998
• A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients witb hypercholesterolemia
  The American Journal of Cardiology, 1997
• Task force 3. Spectrum of risk factors for coronary heart disease
  Journal of the American College of Cardiology, 1996
• Lipid-lowering interventions in angiographic trials
  The American Journal of Cardiology, 1995
• Cholesterol reduction and its impact on coronary artery disease and total mortality
  The American Journal of Cardiology, 1995
• Nonpharmacologic therapy for coronary artery atherosclerosis: Results of primary and secondary prevention trials
  American Heart Journal, 1994
• Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations.
  BMJ, 1991
• SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MEN
  The Lancet, 1986